Dr. Tang brings over 27 years’ experience in medicine, public health, and health economics & outcomes research (HEOR). Currently, he is a founder and principal of TZ Health providing leadership and consulting service to healthcare organizations. Previously, he served as an AVP of HEOR at Agenus, responsible for HEOR strategies globally. He established HEOR function to support the product launches and reimbursement globally. Before joining Agenus, Dr. Tang was the Executive Director/Head of HEOR at BeiGene, Sr. Director of Global HEOR at Teva Pharmaceutical. Senior Director of Health Outcomes Research at Pfizer Emerging Markets, Director of HEOR in JNJ and GSK. He was also an adjuvant professor of China Fudan University and faculty of Zhejiang University Medical School. Meanwhile, Dr. Tang was the 2016-2018 Chair of the HTA (Industry) Committee, Asia Consortium of the International Society of Pharmacoeconomics and Outcomes Research (ISPOR), and a current member of Asia Consortium Executive Committee. Also, he served as a Sr. Fellow at Thomas Jefferson University, School of Population Health. Dr. Tang’s training includes an MD in Preventive Medicine, a PhD in Health Services Research, and an MPH in Health Planning and International Health. He has published more than 40 manuscripts in peer review journals, 100+ abstracts, speeches, and presentations in major scientific congresses. He is knowledgeable in the development of Health Technology Assessment around the world. In addition, he served at the Scientific Committees of International Health Economics Association (iHEA/ASHE), Society for Medical Decision Making (SMDM), and a Peer Reviewer of America Journal of Managed Care, and Cancer Research Journal.